LHCGR and disorder of sexual differentiation: These studies collectively suggest that AAV-mediated Lhcgr gene replacement may serve as a promising therapeutic modality for treating Leydig cell dysfunction-associated male infertility and DSD subtypes characterized by testosterone deficiency.